Literature DB >> 17197963

Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial.

Ming Shi1, Rong-Ping Guo, Xiao-Jun Lin, Ya-Qi Zhang, Min-Shan Chen, Chang-Qing Zhang, Wan Yee Lau, Jin-Qing Li.   

Abstract

OBJECTIVE: To compare the efficacy and safety of partial hepatectomy aiming grossly at a narrow (1 cm) and a wide (2 cm) resection margin in patients with macroscopically solitary hepatocellular carcinoma (HCC). SUMMARY BACKGROUND DATA: For HCC treated with partial hepatectomy, the extent of the margin of liver resection remains controversial despite extensive studies.
METHODS: We conducted a prospective randomized trial in patients with solitary HCC. From January 1999 to February 2003, 169 patients with solitary HCC were stratified according to tumor size and randomized to undergo partial hepatectomy aiming grossly at either a narrow (1 cm) (n = 84) or a wide resection margin (2 cm) (n = 85). Analyses were done on an intention-to-treat basis.
RESULTS: The demographic and pathologic data were similar in the 2 groups. The mean +/- SD for the final resection margin of the narrow and the wide margin groups were 0.7 +/- 0.4 cm and 1.9 +/- 0.6 cm, respectively. There was no significant difference in the morbidity and in-hospital mortality between the 2 groups of patients. The 1-, 2-, 3-, and 5-year overall survival rates for the narrow and the wide margin groups were 92.9%, 83.3%, 70.9%, and 49.1% and 96.5%, 91.8%, 86.9%, and 74.9%, respectively. The difference was significant (stratified log-rank test, P = 0.008). Multivariate analysis identified the presence of micrometastases and the treatment allocation were independent risk factors for tumor-related death. At the time of censor, 75 (44.4%) patients had developed tumor recurrence. All recurrences at the margins of liver resection were observed in the narrow margin group. Multiple tumor recurrence was also significantly higher in the narrow margin group (chi test, P = 0.018). Survival after tumor recurrence was significantly better in the wide margin group than the narrow margin group (log-rank test, P = 0.017).
CONCLUSION: For macroscopically solitary HCC, a resection margin aiming grossly at 2 cm efficaciously and safely decreased postoperative recurrence rate and improved survival outcomes when compared with a gross resection margin aiming at 1 cm, especially for HCC < or =2 cm.

Entities:  

Mesh:

Year:  2007        PMID: 17197963      PMCID: PMC1867934          DOI: 10.1097/01.sla.0000231758.07868.71

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  30 in total

1.  Tables of the number of patients required in clinical trials using the logrank test.

Authors:  L S Freedman
Journal:  Stat Med       Date:  1982 Apr-Jun       Impact factor: 2.373

2.  Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis.

Authors:  J Belghiti; Y Panis; O Farges; J P Benhamou; F Fekete
Journal:  Ann Surg       Date:  1991-08       Impact factor: 12.969

3.  Patterns of intrahepatic recurrence after curative resection of hepatocellular carcinoma.

Authors:  T Matsumata; T Kanematsu; K Takenaka; Y Yoshida; T Nishizaki; K Sugimachi
Journal:  Hepatology       Date:  1989-03       Impact factor: 17.425

4.  Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment.

Authors: 
Journal:  Ann Surg       Date:  1990-03       Impact factor: 12.969

5.  Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis.

Authors:  N Yamanaka; E Okamoto; A Toyosaka; M Mitunobu; S Fujihara; T Kato; J Fujimoto; T Oriyama; K Furukawa; E Kawamura
Journal:  Cancer       Date:  1990-03-01       Impact factor: 6.860

6.  The pathological basis of resection margin for hepatocellular carcinoma.

Authors:  E C Lai; K T You; I O Ng; T W Shek
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

7.  Predictive factors for postoperative recurrence of hepatocellular carcinoma.

Authors:  S Okada; K Shimada; J Yamamoto; T Takayama; T Kosuge; S Yamasaki; M Sakamoto; S Hirohashi
Journal:  Gastroenterology       Date:  1994-06       Impact factor: 22.682

8.  Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection.

Authors:  S C Jwo; J H Chiu; G Y Chau; C C Loong; W Y Lui
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425

9.  Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma.

Authors:  N Nagasue; M Uchida; Y Makino; Y Takemoto; A Yamanoi; T Hayashi; Y C Chang; H Kohno; T Nakamura; H Yukaya
Journal:  Gastroenterology       Date:  1993-08       Impact factor: 22.682

10.  Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection.

Authors:  R Izumi; K Shimizu; T Ii; M Yagi; O Matsui; A Nonomura; I Miyazaki
Journal:  Gastroenterology       Date:  1994-03       Impact factor: 22.682

View more
  149 in total

1.  A special recurrent pattern in small hepatocellular carcinoma after treatment: bile duct tumor thrombus formation.

Authors:  Qing-Yu Liu; Dong-Ming Lai; Chao Liu; Lei Zhang; Wei-Dong Zhang; Hai-Gang Li; Ming Gao
Journal:  World J Gastroenterol       Date:  2011-11-21       Impact factor: 5.742

2.  Liver resection for hepatocellular carcinoma using a microwave tissue coagulator: Experience of 1118 cases.

Authors:  Kazunari Sasaki; Masamichi Matsuda; Masaji Hashimoto; Goro Watanabe
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

3.  Efficacy and safety of preoperative chemoembolization for resectable hepatocellular carcinoma with portal vein invasion: a prospective comparative study.

Authors:  Yong-Fa Zhang; Rong-Ping Guo; Ru-Hai Zou; Jing-Xian Shen; Wei Wei; Shao-Hua Li; Han-Yue OuYang; Hong-Bo Zhu; Li Xu; Xiang-Ming Lao; Ming Shi
Journal:  Eur Radiol       Date:  2015-09-22       Impact factor: 5.315

4.  Central Hepatectomy Still Plays an Important Role in Treatment of Early-Stage Centrally Located Hepatocellular Carcinoma.

Authors:  Chun-Han Chen; Tzu-Hao Huang; Cheng-Chih Chang; Wei-Feng Li; Ting-Lung Lin; Chih-Chi Wang
Journal:  World J Surg       Date:  2017-11       Impact factor: 3.352

5.  An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.

Authors:  Xiu-Ping Zhang; Kang Wang; Xu-Biao Wei; Le-Qun Li; Hui-Chuan Sun; Tian-Fu Wen; Zong-Tao Chai; Zhen-Hua Chen; Jie Shi; Wei-Xing Guo; Dong Xie; Wen-Ming Cong; Meng-Chao Wu; Wan Yee Lau; Shu-Qun Cheng
Journal:  Oncologist       Date:  2019-05-28

6.  The Impact of Tumor Differentiation on the Prognosis of HBV-Associated Solitary Hepatocellular Carcinoma Following Hepatectomy: A Propensity Score Matching Analysis.

Authors:  Junyi Shen; Jiaye Liu; Chuan Li; Tianfu Wen; Lvnan Yan; Jiayin Yang
Journal:  Dig Dis Sci       Date:  2018-05-07       Impact factor: 3.199

7.  Laparoscopic resection for hepatocellular carcinoma: comparison between Middle Eastern and Western experience.

Authors:  Tullio Piardi; Daniele Sommacale; Thomas Baumert; Didier Mutter; Jacques Marescaux; Patrick Pessaux
Journal:  Hepatobiliary Surg Nutr       Date:  2014-04       Impact factor: 7.293

8.  2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2015-05-23       Impact factor: 4.519

9.  Selection criteria for liver resection in patients with hepatocellular carcinoma and chronic liver disease.

Authors:  Spiros-G Delis; Christos Dervenis
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

10.  Impact on Oncological Outcomes and Intent-to-Treat Survival of Resection Margin for Transplantable Hepatocellular Carcinoma in All-Comers and in Patients with Cirrhosis: A Multicenter Study.

Authors:  Chetana Lim; Claire Goumard; Margarida Casellas-Robert; Santiago Lopez-Ben; Laura Lladó; Juli Busquets; Chady Salloum; Maria Teresa Albiol-Quer; Ernest Castro-Gutiérrez; Olivier Rosmorduc; Cyrille Feray; Emilio Ramos; Joan Figueras; Olivier Scatton; Daniel Azoulay
Journal:  World J Surg       Date:  2020-06       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.